Gastrointestinal predictors of severe COVID-19: systematic review and meta-analysis
Author:
Open Access
- 1 January 2020
- journal article
- review article
- Published by Hellenic Society of Gastroenterology in Annals of Gastroenterology
- Vol. 33 (6) , 615-+
Abstract
COVID-19 pandemic has created a need to identify potential predictors of severe disease. We performed a systematic review and meta-analysis of gastrointestinal predictors of severe COVID-19. An extensive literature search was performed using PubMed, Embase, Web of Science and Cochrane. Odds ratio (OR) and mean difference (MD) were calculated for proportional and continuous outcomes using a random-effect model. For each outcome, a 95% confidence interval (CI) and P-value were generated. A total of 83 studies (26912 patients, mean age 43.5±16.4 years, 48.2% female) were included. Gastrointestinal predictors of severe COVID-19 included the presence of diarrhea (OR 1.50, 95%CI 1.10-2.03; P=0.01), elevated serum aspartate aminotransferase (AST) (OR 4.00, 95%CI 3.02-5.28; P<0.001), and elevated serum alanine aminotransferase (ALT) (OR 2.54, 95%CI 1.91-3.37; P<0.001). Significantly higher levels of mean AST (MD 14.78 U/L, 95%CI 11.70-17.86 U/L; P<0.001), ALT (MD 11.87 U/L, 95%CI 9.23-14.52 U/L; P<0.001), and total bilirubin (MD 2.08 mmol/L, 95%CI 1.36-2.80 mmol/L; P<0.001) were observed in the severe COVID-19 group compared to non-severe COVID-19 group. Gastrointestinal symptoms and biomarkers should be assessed early to recognize severe COVID-19.Keywords
This publication has 90 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei ProvinceChinese Medical Journal, 2020
- [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Meta-analysis in clinical trials revisitedContemporary Clinical Trials, 2015
- Drug-Induced Liver InjuryMayo Clinic Proceedings, 2014
- Assessing Bias in Studies of Prognostic FactorsAnnals of Internal Medicine, 2013
- A basic introduction to fixed-effect and random-effects models for meta-analysisResearch Synthesis Methods, 2010
- Systemic Viral Infections and Collateral Damage in the LiverThe American Journal of Pathology, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003